Hinge Health president sells 15,000 shares in plan

Hinge Health, Inc. president James Pursley reported selling a total of 15,000 shares of Class A Common Stock in open-market transactions on February 23, 2026.

Rhea-AI Filing Summary

Hinge Health, Inc. president James Pursley reported selling a total of 15,000 shares of Class A Common Stock in open-market transactions on February 23, 2026. The sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on June 12, 2025.

The shares were sold in three tranches at weighted average prices of $38.76, $39.95, and $40.46, with disclosed price ranges for each group of trades. After these sales, Pursley directly owned 752,231 shares of Hinge Health Class A Common Stock.

Insider Trade Summary

Net Seller: 15,000 shares

Net Sell 3 txns

Insider Pursley James

Role President

Sold 15,000 shs ($590K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	7,874	$38.7553	$305K
Sale	Class A Common Stock	6,818	$39.9476	$272K
Sale	Class A Common Stock	308	$40.4599	$12K

Holdings After Transaction: Class A Common Stock — 752,231 shares (Direct)

Footnotes (4)

1. F1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
2. F2. Represents the weighted average sale price. The lowest price at which shares were sold was $38.435 and the highest price at which shares were sold was $39.41. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
3. F3. Represents the weighted average sale price. The lowest price at which shares were sold was $39.45 and the highest price at which shares were sold was $40.44. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
4. F4. Represents the weighted average sale price. The lowest price at which shares were sold was $40.45 and the highest price at which shares were sold was $40.46. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Hinge Health (HNGE) president James Pursley report?

James Pursley reported selling 15,000 shares of Hinge Health Class A Common Stock. The transactions occurred on February 23, 2026 through open-market sales, reducing his direct holdings to 752,231 shares after the trades were completed.

At what prices did HNGE president James Pursley sell his Hinge Health shares?

The 15,000 shares were sold in three groups at weighted average prices of $38.7553, $39.9476, and $40.4599. Footnotes disclose price ranges within each group, with lows from $38.435 to highs of $40.46 across the reported transactions.

Was the Hinge Health (HNGE) insider sale by James Pursley under a 10b5-1 trading plan?

Yes. The filing states the reported sales were executed under a Rule 10b5-1 trading plan. This plan was adopted by James Pursley on June 12, 2025, allowing pre-scheduled trades independent of day-to-day market or company developments.

How many Hinge Health (HNGE) shares does James Pursley own after the reported sales?

After the reported transactions, James Pursley directly holds 752,231 shares of Hinge Health Class A Common Stock. The Form 4 lists this post-transaction ownership figure following the final sale on February 23, 2026.

How many HNGE shares did Hinge Health president James Pursley sell in total?

In total, James Pursley sold 15,000 shares of Hinge Health Class A Common Stock. The Form 4 transaction summary shows three sale entries adding up to 15,000 shares on February 23, 2026, all classified as open-market sales.

What does the Form 4 for Hinge Health (HNGE) reveal about James Pursley’s trading activity?

The Form 4 reveals that company president James Pursley executed three open-market sales totaling 15,000 shares. These trades were conducted on February 23, 2026 under a previously adopted Rule 10b5-1 plan, with detailed weighted average prices and price ranges disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:21 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pursley James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/23/2026		S(1)		7,874	D	$38.7553(2)	759,357	D
Class A Common Stock	02/23/2026		S(1)		6,818	D	$39.9476(3)	752,539	D
Class A Common Stock	02/23/2026		S(1)		308	D	$40.4599(4)	752,231	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.

2. Represents the weighted average sale price. The lowest price at which shares were sold was $38.435 and the highest price at which shares were sold was $39.41. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

3. Represents the weighted average sale price. The lowest price at which shares were sold was $39.45 and the highest price at which shares were sold was $40.44. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

4. Represents the weighted average sale price. The lowest price at which shares were sold was $40.45 and the highest price at which shares were sold was $40.46. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

	/s/ James Budge, Attorney-in-Fact	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.